Overview

This trial is active, not recruiting.

Conditions diabetes, obesity
Sponsor Joslin Diabetes Center
Start date August 2006
End date September 2020
Trial size 110 participants
Trial identifier NCT01937845, CHS#: 06-26

Summary

Evaluating the health outcomes of patients that were enrolled in Joslin's Why WAIT Program. These outcomes include BMI, A1C, lipid profile.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Measure
Weight loss of 7% body weight
time frame: 13 weeks

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: - Patients with Type 2 diabetes with BMI over 35 Exclusion Criteria: - Patients with type 1 diabetes

Additional Information

Official title Evaluating the Health Outcomes of the Joslin Why WAIT? Program (Weight Achievement & Intensive Treatment Program)
Description This study is aimed to evaluate the health outcomes of patients enrolled in Joslin's Why WAIT Program. This program aims to control diabetes and help patients lose weight.
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Joslin Diabetes Center.